$PRAN News U.
Post# of 102911
Posted On: 12/08/2014 12:20:26 PM
$PRAN News
U.S. stocks rise; S&P 500, Nasdaq notch quarterly gains
3:47 p.m. March 31, 2014
- Anora Mahmudova
Keurig biggest S&P 500 loser; BlackBerry extends losses
2:30 p.m. March 31, 2014
- Sue Chang
Biotech's shares fall 70% on tests
11:39 a.m. March 31, 2014
- Russ Britt
U.S. stock futures extend gains ahead of Yellen
7:58 a.m. March 31, 2014
- Barbara Kollmeyer
U.S.-listed shares of Prana sink after drug trial
6:50 a.m. March 31, 2014
- Saumya Vaishampayan
Prana sinks 62% after Alzheimer's study fails
6:22 a.m. March 31, 2014
- Barbara Kollmeyer
U.S. stocks edge up; Nasdaq gains for 8th day in a row
4:38 p.m. Feb. 18, 2014
- Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal
4:11 p.m. Feb. 18, 2014
- Sue Chang
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap
4:06 p.m. Feb. 18, 2014
- blogs.marketwatch.com
Prana's wild ride continues with shares surging on drug test results
3:24 p.m. Feb. 18, 2014
- Russ Britt
Prana's Huntington disease therapy meets endpoints
11:51 a.m. Feb. 18, 2014
- MarketWatch.com
Prana Biotechnology up 19% in premarket
8:58 a.m. Dec. 6, 2012
- Steve Gelsi
Prana has OK for Alzheimer's study; shares rise
1:30 p.m. Nov. 22, 2011
- MarketWatch.com
Monday’s biggest gaining and declining stocks
3:30 p.m. Sept. 19, 2011
- Laura Mandaro
Prana, European drug makers lead rally
2:26 p.m. April 20, 2011
- Val Brickates Kennedy
Prana climbs 14% on business update
10:18 a.m. April 20, 2011
- Val Brickates Kennedy
Xoma, Prana lead biotech stocks south
12:19 p.m. March 23, 2011
- Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks
3:56 p.m. March 22, 2011
- Kate Gibson
Prana shines in drugstock trading
10:02 a.m. March 22, 2011
- Val Brickates Kennedy
Prana rockets on Alzheimer's study
9:20 a.m. March 22, 2011
- Val Brickates Kennedy
Genervon ALS drug shows encouraging results
7:27 a.m. Oct. 20, 2014
- Seeking Alpha
Horizon Pharma's Actimmune Gets Orphan Drug Designation - Analyst Blog
1:00 p.m. Oct. 7, 2014
- Zacks.com
Prana Biotechnology Up on Orphan Drug Status for PBT2 - Analyst Blog
4:35 p.m. Sept. 8, 2014
- Zacks.com
Why Prana Biotechnology (PRAN) Stock Is Surging Today
8:46 a.m. Sept. 5, 2014
- TheStreet.com
Why Prana Biotechnology (PRAN) Stock Is Surging Today
1:05 p.m. July 17, 2014
- TheStreet.com
Prana shares up premarket on clinical trial update
8:22 a.m. July 17, 2014
- Seeking Alpha
Prana Biotechnology (PRAN) Stock Suddenly Surges
2:28 p.m. May 27, 2014
- TheStreet.com
Prana Biotechnology Is Still A Short After Recent Alzheimer's Failure
3:15 p.m. April 14, 2014
- Seeking Alpha
Are These Three Biotech Companies Still Worth A Gamble?
10:16 a.m. April 14, 2014
- Seeking Alpha
Prana collapses after trial fails
5:57 a.m. March 31, 2014
- Seeking Alpha
Prana Biotechnology - A Gamble Worth Taking For Both Long- And Short-Term Investors
2:49 p.m. March 20, 2014
- Seeking Alpha
Prana to join Aussie index for top 300 companies
9:00 a.m. March 11, 2014
- Seeking Alpha
Alzheimer's Research Stocks - Technical And Other Considerations
8:38 a.m. March 7, 2014
- Seeking Alpha
Prana Biotech Alzheimer approach supported by study
10:49 a.m. March 6, 2014
- Seeking Alpha
Alzheimer's Dementia: Eli Lilly's Solanezumab Or Prana's PBT2, Which Would You Take?
3:24 p.m. March 4, 2014
- Seeking Alpha
Prana: Right Drug, Wrong Dose
9:38 a.m. March 3, 2014
- Seeking Alpha
Bipolar Prana: PBT2 For Alzheimer's Dementia, Implications Of The Upcoming IMAGINE Trial Results
6:45 a.m. March 1, 2014
- Seeking Alpha
Following The Latest In Alzheimer's Research As An Investor
10:12 a.m. Feb. 24, 2014
- Seeking Alpha
Positive Phase 2 Results For Prana Biotechnology In Huntington's Disease: Behind The Smoke And Mirrors
12:45 p.m. Feb. 22, 2014
- Seeking Alpha
SA PRO: Top Long And Short Ideas, Thursday February 20
7:30 a.m. Feb. 21, 2014
- Seeking Alpha
The Lancet Neurology Publishes Prana's Huntington
Disease Trial
11:01 a.m. Nov. 19, 2014
- BusinessWire - BZX
Analyst Scanner on Biotech Equities - Prana Biotechnology, CytRx, Insmed, Dynavax Technologies, and Vertex Pharma
8:15 a.m. Sept. 11, 2014
- PR Newswire - PRF
Prana receives FDA Orphan Drug Designation for PBT2 for Huntington Disease
6:45 a.m. Sept. 5, 2014
- PR Newswire - PRF
Prana Alzheimer's disease Development Program update
3:10 p.m. July 17, 2014
- PR Newswire - PRF
Biotech Equities Technical Momentum -- Research on Organovo, Prana Biotechnology, Isis Pharma, and Pharmacyclics
6:04 a.m. July 14, 2014
- PR Newswire - PRF
Executive Appointments and Technical Updates - Analyst Notes on Aeri Pharmaceuticals, DaVita, Prana Biotechnology, Raptor and Avanir Pharmaceuticals
4:10 a.m. July 14, 2014
- PR Newswire - PRF
Stock Watchout on Biotech Industry -- Research on Isis Pharma, Pharmacyclics, Amarin, and Prana Biotechnology
6:10 a.m. June 11, 2014
- PR Newswire - PRF
Biotech Equities Coverage -- Research on Isis Pharma, Pharmacyclics, Prana Biotech, and United Therapeutics
10:29 a.m. May 19, 2014
- PR Newswire - PRF
World leader in movement disorders Professor Ira Shoulson joins Prana Board
6:30 a.m. May 14, 2014
- PR Newswire - PRF
Technical Report on Top Gainers -- Research on Centene, Prana Biotechnology, Horizon Pharma, and Scientific Games
10:34 a.m. April 23, 2014
- PR Newswire - PRF
Zeldes Haeggquist & Eck LLP Announces Investigation of Prana
Biotechnology Limited
8:03 a.m. April 23, 2014
- BusinessWire - BZX
Prana Biotechnology Stock Hits New Low
9:47 a.m. April 16, 2014
- ACCESSWIRE
FDA Panel Grants Market Approval of MannKind Corp.'s Inhalable Insulin
8:49 a.m. April 2, 2014
- ACCESSWIRE
Coca-Cola Falls as Soda Sales Drop for 9th Straight Year
1:00 a.m. April 1, 2014
- ACCESSWIRE
Prana Biotechnology announces preliminary results of Phase 2 IMAGINE trial of PBT2 in Alzheimer's disease
6:05 a.m. March 31, 2014
- PR Newswire - PRF
Biotech Equities Technical Study -- Research on Prana Biotechnology, Amarin, United Therapeutic, and OPKO Health
11:19 a.m. March 28, 2014
- PR Newswire - PRF
Huntington's Reviewed by NeuroPerspective
8:30 a.m. March 4, 2014
- PR Newswire - PRF
Forest Labs to be acquired by Actavis for $25 billion while Prana Biotech surges on drug results
12:23 a.m. Feb. 19, 2014
- ACCESSWIRE
Prana Meets Primary Endpoint in Phase 2 REACH2HD Clinical Study of PBT2 for Treating Huntington Disease
6:02 a.m. Feb. 18, 2014
- PR Newswire - PRF
Products Recall, Stock Price Updates, Technology Solution Deployment, Update on Extension Trial, and Donations - Research Report on Alexion Pharma, Questcor, BioMarin Pharma, Allscripts, and Prana
8:00 a.m. Dec. 20, 2013
- PR Newswire
U.S. stocks rise; S&P 500, Nasdaq notch quarterly gains
3:47 p.m. March 31, 2014
- Anora Mahmudova
Keurig biggest S&P 500 loser; BlackBerry extends losses
2:30 p.m. March 31, 2014
- Sue Chang
Biotech's shares fall 70% on tests
11:39 a.m. March 31, 2014
- Russ Britt
U.S. stock futures extend gains ahead of Yellen
7:58 a.m. March 31, 2014
- Barbara Kollmeyer
U.S.-listed shares of Prana sink after drug trial
6:50 a.m. March 31, 2014
- Saumya Vaishampayan
Prana sinks 62% after Alzheimer's study fails
6:22 a.m. March 31, 2014
- Barbara Kollmeyer
U.S. stocks edge up; Nasdaq gains for 8th day in a row
4:38 p.m. Feb. 18, 2014
- Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal
4:11 p.m. Feb. 18, 2014
- Sue Chang
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap
4:06 p.m. Feb. 18, 2014
- blogs.marketwatch.com
Prana's wild ride continues with shares surging on drug test results
3:24 p.m. Feb. 18, 2014
- Russ Britt
Prana's Huntington disease therapy meets endpoints
11:51 a.m. Feb. 18, 2014
- MarketWatch.com
Prana Biotechnology up 19% in premarket
8:58 a.m. Dec. 6, 2012
- Steve Gelsi
Prana has OK for Alzheimer's study; shares rise
1:30 p.m. Nov. 22, 2011
- MarketWatch.com
Monday’s biggest gaining and declining stocks
3:30 p.m. Sept. 19, 2011
- Laura Mandaro
Prana, European drug makers lead rally
2:26 p.m. April 20, 2011
- Val Brickates Kennedy
Prana climbs 14% on business update
10:18 a.m. April 20, 2011
- Val Brickates Kennedy
Xoma, Prana lead biotech stocks south
12:19 p.m. March 23, 2011
- Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks
3:56 p.m. March 22, 2011
- Kate Gibson
Prana shines in drugstock trading
10:02 a.m. March 22, 2011
- Val Brickates Kennedy
Prana rockets on Alzheimer's study
9:20 a.m. March 22, 2011
- Val Brickates Kennedy
Genervon ALS drug shows encouraging results
7:27 a.m. Oct. 20, 2014
- Seeking Alpha
Horizon Pharma's Actimmune Gets Orphan Drug Designation - Analyst Blog
1:00 p.m. Oct. 7, 2014
- Zacks.com
Prana Biotechnology Up on Orphan Drug Status for PBT2 - Analyst Blog
4:35 p.m. Sept. 8, 2014
- Zacks.com
Why Prana Biotechnology (PRAN) Stock Is Surging Today
8:46 a.m. Sept. 5, 2014
- TheStreet.com
Why Prana Biotechnology (PRAN) Stock Is Surging Today
1:05 p.m. July 17, 2014
- TheStreet.com
Prana shares up premarket on clinical trial update
8:22 a.m. July 17, 2014
- Seeking Alpha
Prana Biotechnology (PRAN) Stock Suddenly Surges
2:28 p.m. May 27, 2014
- TheStreet.com
Prana Biotechnology Is Still A Short After Recent Alzheimer's Failure
3:15 p.m. April 14, 2014
- Seeking Alpha
Are These Three Biotech Companies Still Worth A Gamble?
10:16 a.m. April 14, 2014
- Seeking Alpha
Prana collapses after trial fails
5:57 a.m. March 31, 2014
- Seeking Alpha
Prana Biotechnology - A Gamble Worth Taking For Both Long- And Short-Term Investors
2:49 p.m. March 20, 2014
- Seeking Alpha
Prana to join Aussie index for top 300 companies
9:00 a.m. March 11, 2014
- Seeking Alpha
Alzheimer's Research Stocks - Technical And Other Considerations
8:38 a.m. March 7, 2014
- Seeking Alpha
Prana Biotech Alzheimer approach supported by study
10:49 a.m. March 6, 2014
- Seeking Alpha
Alzheimer's Dementia: Eli Lilly's Solanezumab Or Prana's PBT2, Which Would You Take?
3:24 p.m. March 4, 2014
- Seeking Alpha
Prana: Right Drug, Wrong Dose
9:38 a.m. March 3, 2014
- Seeking Alpha
Bipolar Prana: PBT2 For Alzheimer's Dementia, Implications Of The Upcoming IMAGINE Trial Results
6:45 a.m. March 1, 2014
- Seeking Alpha
Following The Latest In Alzheimer's Research As An Investor
10:12 a.m. Feb. 24, 2014
- Seeking Alpha
Positive Phase 2 Results For Prana Biotechnology In Huntington's Disease: Behind The Smoke And Mirrors
12:45 p.m. Feb. 22, 2014
- Seeking Alpha
SA PRO: Top Long And Short Ideas, Thursday February 20
7:30 a.m. Feb. 21, 2014
- Seeking Alpha
The Lancet Neurology Publishes Prana's Huntington
Disease Trial
11:01 a.m. Nov. 19, 2014
- BusinessWire - BZX
Analyst Scanner on Biotech Equities - Prana Biotechnology, CytRx, Insmed, Dynavax Technologies, and Vertex Pharma
8:15 a.m. Sept. 11, 2014
- PR Newswire - PRF
Prana receives FDA Orphan Drug Designation for PBT2 for Huntington Disease
6:45 a.m. Sept. 5, 2014
- PR Newswire - PRF
Prana Alzheimer's disease Development Program update
3:10 p.m. July 17, 2014
- PR Newswire - PRF
Biotech Equities Technical Momentum -- Research on Organovo, Prana Biotechnology, Isis Pharma, and Pharmacyclics
6:04 a.m. July 14, 2014
- PR Newswire - PRF
Executive Appointments and Technical Updates - Analyst Notes on Aeri Pharmaceuticals, DaVita, Prana Biotechnology, Raptor and Avanir Pharmaceuticals
4:10 a.m. July 14, 2014
- PR Newswire - PRF
Stock Watchout on Biotech Industry -- Research on Isis Pharma, Pharmacyclics, Amarin, and Prana Biotechnology
6:10 a.m. June 11, 2014
- PR Newswire - PRF
Biotech Equities Coverage -- Research on Isis Pharma, Pharmacyclics, Prana Biotech, and United Therapeutics
10:29 a.m. May 19, 2014
- PR Newswire - PRF
World leader in movement disorders Professor Ira Shoulson joins Prana Board
6:30 a.m. May 14, 2014
- PR Newswire - PRF
Technical Report on Top Gainers -- Research on Centene, Prana Biotechnology, Horizon Pharma, and Scientific Games
10:34 a.m. April 23, 2014
- PR Newswire - PRF
Zeldes Haeggquist & Eck LLP Announces Investigation of Prana
Biotechnology Limited
8:03 a.m. April 23, 2014
- BusinessWire - BZX
Prana Biotechnology Stock Hits New Low
9:47 a.m. April 16, 2014
- ACCESSWIRE
FDA Panel Grants Market Approval of MannKind Corp.'s Inhalable Insulin
8:49 a.m. April 2, 2014
- ACCESSWIRE
Coca-Cola Falls as Soda Sales Drop for 9th Straight Year
1:00 a.m. April 1, 2014
- ACCESSWIRE
Prana Biotechnology announces preliminary results of Phase 2 IMAGINE trial of PBT2 in Alzheimer's disease
6:05 a.m. March 31, 2014
- PR Newswire - PRF
Biotech Equities Technical Study -- Research on Prana Biotechnology, Amarin, United Therapeutic, and OPKO Health
11:19 a.m. March 28, 2014
- PR Newswire - PRF
Huntington's Reviewed by NeuroPerspective
8:30 a.m. March 4, 2014
- PR Newswire - PRF
Forest Labs to be acquired by Actavis for $25 billion while Prana Biotech surges on drug results
12:23 a.m. Feb. 19, 2014
- ACCESSWIRE
Prana Meets Primary Endpoint in Phase 2 REACH2HD Clinical Study of PBT2 for Treating Huntington Disease
6:02 a.m. Feb. 18, 2014
- PR Newswire - PRF
Products Recall, Stock Price Updates, Technology Solution Deployment, Update on Extension Trial, and Donations - Research Report on Alexion Pharma, Questcor, BioMarin Pharma, Allscripts, and Prana
8:00 a.m. Dec. 20, 2013
- PR Newswire
(0)
(0)